Frontiers | CCR5 - Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41 | Cellular and Infection Microbiology User Timetotellthetruth9, in the advancingleronlimab subreddit, 07 Jun 2022